- Home
- BFRI vs IOBT Comparison
BFRI vs IOBT Comparison
Compare BFRI & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | IOBT |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | Denmark |
| Employees | 94 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 12.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BFRI | IOBT |
|---|---|---|
| Price | $1.14 | $0.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $2.75 | $2.25 |
| AVG Volume (30 Days) | 121.5K | ★ 186.6M |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.36 | N/A |
| Revenue Next Year | $16.98 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.03 |
| 52 Week High | $1.19 | $2.79 |
Technical Indicators
Market Signals| Indicator | BFRI | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 64.13 | 25.94 |
| Support Level | $0.79 | N/A |
| Resistance Level | $1.17 | $0.22 |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 73.68 | 15.92 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.